Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon

NCT02688270 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Raynaud's Phenomenon Secondary to Connective Tissue Disease

Interventions

DRUG: Vascana (0.9% nitroglycerin cream)
DRUG: Vehicle Cream (placebo)

Sponsor

Covis Pharma S.à.r.l.